Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis
Clinical trial NCT02784496 · COMPLETED
Trial details
- NCT number
- NCT02784496
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-29
- Primary completion
- 2024-01-23
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.